Central retinal artery occlusion in a patient with ANCA-negative Churg-Strauss syndrome Full Text
Clinical Ophthalmology, 08/10/2012
Kumano Y et al. – Specific therapy to alter inflammation, blood coagulation, and rheology reportedly plays an important role in ANCA–positive patients with Churg–Strauss syndrome who develop CRAO. Regardless of ANCA status, high–dose corticosteroids should be considered for CRAO in patients with Churg–Strauss syndrome, as discussed in this case.